With the thoughtfully curated program and the practical events app, our Biologics schedule is quickly filling up.

So far we have enrolled for the following keynotes:

• Opportunities for biosimilar product differentiation through drug product enhancement, presented by Andreas Seidl from Formycon AG
• New Era of Low-Cost Development of Biosimilars: No more testing in patients, presented by Sarfaraz K. Niazi from the University of Illinois Chicago
• ATL-105, a new broadband antiviral therapy for inhalation, presented by Dr. Rüdiger Jankowsky from AATec Medical GmbH
• JJP-1008: A Novel Checkpoint Inhibitor for Reversing Immunosuppressive TME in Cancer Treatment, presented by Louis Boon from JJP Biologics
• Engaging the Full Immunity Cycle with Innate Cell Engagers (ICE®): New Therapeutic Avenues for Patients, presented by Anna Lisa Guendner from Affimed GmbH

Between the keynotes, there are still some open slots for meetings. Please contact us if you would like to discuss QP Certification, GMP, or Import to the EU.

𝐖𝐡𝐞𝐧? 10th to 12th October 2023
𝐎𝐧-𝐬𝐢𝐭𝐞 𝐞𝐱𝐩𝐞𝐫𝐭𝐢𝐬𝐞: Dr. Lucia Vitellozzi and Dr. Ulrich Korell

Do you have questions about QP Certification, GMP or Import to the EU? Take this opportunity to gain valuable insights from us. Send us a message or arrange a meeting with us through the Festival App.

We are immensely pleased to contribute to the advancement of innovative biotech medicines, which often require ultra-low-temperature storage at -80°C, by taking on the crucial task of temperature-appropriate storage.

Upon customer request, we have installed multiple ultra-low-temperature freezers in our storage facility within four weeks. These have been qualified and commissioned in accordance with stringent pharmaceutical standards. A backup freezer is available in case of unexpected disruptions. Additionally, the storage facility is secured with an alarm system and an emergency power supply.

It’s important to us to be able to respond flexibly to individual client requirements while simultaneously having the capacity to handle complex projects in a timely manner. At PharmaKorell, we offer the best of both worlds—a multidisciplinary team that brings the competencies of a larger organisation but retains the adaptability and attention to detail expected from smaller companies.

Following the successful completion of auditor training, which comprised an external course and participation in ten GMP audits, we are pleased to announce the promotion of Dr. Matthias Barth to the role of Lead Auditor and Senior Consultant.

Originating from the field of geology, he earned his Doctor of Philosophy (Ph.D.) from the esteemed Harvard University.

Upon completing his studies in the USA, Dr. Barth initially worked in analytics before transitioning into the realm of medical technology (ISO 13485).

Since 2019, Matthias has been a consultant at PharmaKorell GmbH, specialising in quality assurance, quality control, and warehousing/logistics. His promotion underscores his unwavering commitment and professional expertise.

We began the day with a journey to the impressive Vitra Campus in Weil am Rhein. Over a communal breakfast, we fortified ourselves before embarking on a guided tour through the world-class architecture of the campus. Among other things, we had the opportunity to visit the current exhibition, “Garden Futures”, at the Vitra Design Museum and to take a stroll through the garden designed by Piet Oudolf.

Subsequently, we made our way to the Löwen Restaurant in Eimeldingen, where we had time to reflect upon and share our morning experiences.

In the afternoon, at the suggestion of one of our colleagues who volunteers there, we visited the Technical Relief Agency in Lörrach.

We are grateful for a well-spent day amongst colleagues.